Psychedelics Psilocybin-like drug may help people suffering from anorexia: COMPASS study The majority of participants reported significant improvements in their overall mental health Rowan DunneJuly 28, 2023
Psychedelics Filament Health to list on Nasdaq through new business arrangement The transaction is expected to close in Q4 this year Rowan DunneJuly 19, 2023
Psychedelics Majority of Americans support regulating psychedelics: UC Berkeley survey The survey results follow the city of Berkeley decriminalizing psychedelic plants and fungi on Tuesday Rowan DunneJuly 13, 2023
Psychedelics UC San Diego receives US$1.5M for cognitive research on DMT Fund supporting the institution's Psychedelics and Health Research Initiative was provided by philanthropist Eugene Jhong Rowan DunneJuly 11, 2023
Psychedelics Windsor police raid new mushroom dispensary, owners open up shop next day 'We have a big team behind us and we have a lot of people supporting us' said the store's co-owner on Thursday Rowan DunneJuly 7, 2023
Psychedelics NeoLumina Bioscience to develop Filament Health patented psilocybin as eating disorders treatment Filament will be licensing NeoLumina with its PEX010 drug and associated IP for commercial and clinical development Rowan DunneJuly 3, 2023
Psychedelics FDA publishes first draft guidance document for psychedelics research It aims to highlight relevant considerations for researchers investigating the therapeutic value of psychedelics Rowan DunneJune 23, 2023
Psychedelics Optimi Health to supply MDMA for new psychedelic therapy program at Numinus clinics The experiential training will only be available through Numinus and will utilize the protocol of MAPS Rowan DunneJune 15, 2023
News Apex Labs U.S.-based supplier of psilocybin approved by Health Canada The company has a specific focus on Veteran patients Natalia Buendia CalvilloJune 9, 2023
News Colorado governor signs bill regulating psychedelics The Natural Medicine Health act will take effect on July 1 Natalia Buendia CalvilloMay 26, 2023